Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional Study of the Change in Joint Health in Adult Patients With Haemophilia A After Switching to Prophylaxis With Turoctocog Alfa Pegol (N8-GP)

NCT05621746 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT05621746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional Study of the Change in Joint Health in Adult Patients With Haemophilia A After Switching to Prophylaxis With Turoctocog Alfa Pegol (N8-GP)
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 23, 2022
Completion date
April 30, 2026
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a